Liaoning, China

Jixia Wang

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jixia Wang: Innovator in Cyclic Amine Derivatives

Introduction

Jixia Wang is a notable inventor based in Liaoning, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cyclic amine derivatives. His work focuses on creating compounds that can be utilized in the treatment of various diseases.

Latest Patents

Jixia Wang holds a patent for a compound titled "2-(2,2-diarylethyl)-cyclic amine derivative or salt, synthesis method, application and composition thereof." This patent describes a synthesis method and application for a specific cyclic amine derivative. The biological activity tests indicate that this compound exhibits good M-receptor antagonistic activity. It has potential applications as an active component in drugs aimed at treating diseases mediated or regulated by muscarinic receptors, including asthma, chronic obstructive pulmonary disease (COPD), overactive bladder (OAB), and several mental health conditions.

Career Highlights

Jixia Wang is affiliated with the Chinese Academy of Sciences, where he conducts his research and development work. His innovative approach to drug development has positioned him as a key figure in his field.

Collaborations

Jixia Wang has collaborated with notable colleagues, including Xinmiao Liang and Changjian Wang. Their combined expertise contributes to the advancement of research in medicinal chemistry.

Conclusion

Jixia Wang's contributions to the field of cyclic amine derivatives highlight his role as an influential inventor. His patented work has the potential to impact the treatment of various medical conditions significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…